Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:49 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
NCT04591808 · Institut de Recherches Internationales Servier · PHASE3 · terminated · last registry update 2023-10-18 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “for strategic reasons” | – | Registry record, Institut de Recherches Internationales Servier |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against HMGCR within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2024-10-17Phase 3 first posted: Hyundai Pharm, Ezetimibe/Rosuvastatin/Candesartan/Amlodipine + Candesartan/Amlodipine (NCT06646354)
- 2024-10-15Results posted on the registry: National Institute of Allergy and Infectious Diseases (NIAID), Pitavastatin + Placebo (NCT02344290)
- 2024-08-19Phase 3 first posted: The George Institute, Atorvastatin (NCT06559072)
- 2024-08-02Results posted on the registry: Shionogi, MT-1186 + Rosuvastatin (NCT04481789)
- 2024-04-11Phase 3 first posted: Kafrelsheikh University, Atorvastatin 40 Mg Oral Tablet + Rosuvastatin 20mg (NCT06360120)
- 2024-04-10Phase 3 first posted: Kafrelsheikh University, Atorvastatin 40mg + Rosuvastatin 20mg (NCT06358313)
- 2024-03-20Results posted on the registry: Wake Forest University Health Sciences, moderate- or high-intensity statin/ rosuvastatin (NCT05742841)
- 2024-03-19Phase 3 first posted: Kirby Institute, Dapagliflozin 10mg Tab + Pitavastatin 4 Mg Oral Tablet (NCT06317051)
- 2023-12-18Results posted on the registry: Massachusetts General Hospital, Placebo + Atorvastatin (NCT02943590)
- 2023-07-27Phase 3 first posted: Northern California Institute of Research and Education, Polycap (NCT05963568)
- 2023-04-04Phase 3 first posted: Tampere University Hospital, Atorvastatin (NCT05796973)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision